The Walt Disney Company (a Delaware corporation) Fixed Rate Medium-Term Notes TERMS AGREEMENT

Exhibit 1.1

The Walt Disney Company

(a Delaware corporation)

Fixed Rate
Medium-Term Notes

TERMS AGREEMENT

November 29, 2007

The Walt Disney Company

500 South Buena Vista Street

Burbank, California  91521

Attention: Legal Department

Re:          Distribution Agreement dated March 10, 2005

Reference is made to the Distribution Agreement dated March 10, 2005, which is incorporated herein by reference. The undersigned (the “Underwriters”) severally agree to purchase the following principal amounts of Medium-Term Notes, Series C, entitled 4.70% Global Notes due 2012 (the “Notes”):

Merrill Lynch, Pierce, Fenner & Smith Incorporated is acting as the representative (the “Representative”) of the several underwriters.

Stated Maturity Date: December 1, 2012

Original Issue Date: December 4, 2007

Trade Date: November 29, 2007

Issue Price: 99.772%

Discount or Commission: 0.35%

Settlement Date and Time: December 4, 2007 at 7 a.m. Pacific Time

1

Additional Terms:

Interest Rate: 4.70%

Interest Payment Dates: June 1 and December 1, commencing June 1, 2008

Day Count Convention:

30/360 for the period from December 4, 2007 to December 1, 2012

The certificate referred to in Section 6(a) of the Distribution Agreement and the opinions referred to in Section 6(b) of the Distribution Agreement will not be required. The reasonable fees and disbursements of counsel to the Underwriters incurred in connection with the issuance and sale of the Notes will be paid by the Underwriters. On the Settlement Date, The Walt Disney Company (the “Company”) shall deliver to the Underwriters (a) the accountants’ letter referred to in Section 6(c) of the Distribution Agreement, dated the Settlement Date, and (b) a letter, dated the Settlement Date and substantially in the form of Schedule I hereto.

In addition, solely for the purposes of this Terms Agreement, the Distribution Agreement is hereby amended as follows:

1.           The representation and warranties in Section 1(a) shall be deemed made as of the Applicable Time (as defined below).

2.           The following representations and warranties are added to Section 1(a) (Representations and Warranties) as subsections (x) and (xi):

(x)  As of the Applicable Time, the Pricing Disclosure Package did not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; except that this representation and warranty does not apply to statements or omissions in the Pricing Disclosure Package made in reliance upon information furnished to the Company in writing by or on behalf of the Underwriters expressly for use therein. “Applicable Time” means 3:30 p.m. (New York City time) on the date of this Terms Agreement. “Pricing Disclosure Package” means the Prospectus as amended and supplemented as of the Applicable Time together with each Issuer Free Writing Prospectus listed on Schedule II hereto. “Issuer Free Writing Prospectus” means each “issuer free writing prospectus” (as defined in Rule 433 of the 1933 Act Regulations) relating to the Notes.

(xi)  (i) At the earliest time after the filing of the Registration Statement that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) of the 1933 Act Regulations) of the Notes and (ii) at the date of this Terms Agreement, the Company was not and is not and “ineligible issuer,” as defined in Rule 405 of the 1933 Act Regulations.

2

3.           Section 3 (Covenants of the Company) is amended as follows:

A.            to insert the words “or the Pricing Disclosure Package” following each reference to the word “Prospectus” in Section 3(d); and

B.            to add as subsection (i):

“Issuer Free Writing Prospectus. The Company will comply with Rule 433 of the 1933 Act Regulations with respect to each Issuer Free Writing Prospectus.”

4.           Section 7 (Indemnification) is amended as follows:

A.            to insert the words “or any Issuer Free Writing Prospectus” following each reference to the word “Prospectus”;

B.            to replace the words “sale of a Note or Notes to” in clause (B) of paragraph (a)(iii) with the words “entry into the contract of sale of Notes with;” and

C.            to insert the following in Section 7(a)(iii)(B) following the first reference to the word “supplemented”:

“reasonably sufficiently far in advance of the Applicable Time so as to permit delivery of such Issuer Free Writing Prospectus to investors immediately at such time,.”

5.           The following section is added as Section 14:

“Covenant of the Underwriters. Each Underwriter covenants with the Company that, except as provided herein, unless it has obtained or will obtain, as the case may be, the prior written consent of the Company, it has not made and will not make any offer relating to the Notes that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405 of the 1933 Act Regulations) required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the 1933 Act Regulations. Notwithstanding anything to the contrary contained herein, the Company consents to the use by the Underwriters of a free writing prospectus that contains only (a)(i) information describing the preliminary terms of the Notes or their offering or (ii) information that describes the final terms of the Notes and that is included in the final term sheet of the Company listed on Schedule II hereto or (b) other customary information that is neither “issuer information,” as defined in Rule 433, or otherwise an Issuer Free Writing Prospectus.”

Default by One or More of the Underwriters: If one or more of the Underwriters shall fail at the Original Issue Date to purchase the Notes which it or they are obligated to purchase under this Terms Agreement (the “Defaulted Notes”), the Representative shall have the right, within 24 hours thereafter, to make arrangements for one or more of the non-defaulting Underwriters, or any other underwriters satisfactory to the Company, to purchase all, but not less than all, of the Defaulted Notes in such amounts as may be agreed upon and upon the terms herein set forth; if,

3

however, the Representative shall not have completed such arrangements within such 24-hour period, then:

(a)           if the number of Defaulted Notes does not exceed 10% of the aggregate principal amount of the Notes to be purchased hereunder, each of the non-defaulting Underwriters shall be obligated, severally and not jointly, to purchase the full amount thereof in the proportions that their respective underwriting obligations hereunder bear to the underwriting obligations of all non-defaulting Underwriters, or

(b)           if the number of Defaulted Notes exceeds 10% of the aggregate principal amount of the Notes to be purchased hereunder, this Terms Agreement shall terminate without liability on the part of any non-defaulting Underwriter.

No action taken pursuant to this provision shall relieve any defaulting Underwriter from liability in respect of its default.

In the event of any such default which does not result in a termination of this Terms Agreement, the Representative or the Company shall have the right to postpone the Original Issue Date for a period not exceeding seven days in order to effect any required changes in the pricing supplement dated November 29, 2007 relating to the Notes or in any other documents or arrangements.

European Economic Area: In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a “Relevant Member State”), each Underwriter represents and agrees that with effect from and including the date on which the Prospectus Directive is implemented in that Relevant Member State (the “Relevant Implementation Date”) it has not made and will not make an offer of the Notes to the public in that Relevant Member State prior to the publication of a prospectus in relation to the Notes which has been approved by the competent authority in that Relevant Member State, or where appropriate, approved in another Relevant Member State and notified to the competent authority in that Relevant Member State, all in accordance with the Prospectus Directive, except that it may, with effect from and  including the Relevant Implementation Date, make an offer of Notes to the public in that Relevant Member State at any time:

•       to legal entities which are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate purpose is solely to invest in securities;

•       to any legal entity which has two or more of (1) an average of at least 250 employees during the last financial year; (2) a total balance sheet of more than €43,000,000; and (3) an annual net turnover of more than €50,000,000, as shown in its last annual or consolidated accounts; or

•       in any other circumstances which do not require the publication by the Company of a prospectus pursuant to Article 3 of the Prospectus Directive.

4

For the purposes of this provision, the expression an “offer of Notes to the public” means the communication in any form and by any means of sufficient information on the terms of the offer and the Notes to be offered so as to enable an investor to decide to purchase or subscribe for the Notes, as the same may be varied in that Member State by any measure implementing the Prospectus Directive. The expression “Prospectus Directive” means Directive 2003/71/EC and includes any relevant implementing measure in each Relevant Member State. References to “€” are to euros.

United Kingdom: Each Underwriter represents and agrees that:

•       it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21  or the Financial Services and Markets Act 2000 (the “FSMA”)) received by it in connection with the issue or sale of the Notes in circumstances in which Section 21(1) of the FSMA does not apply to the Company; and

•       it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the Notes in, from or otherwise involving the United Kingdom.

Each Underwriter severally represents to and agrees with the Company that it has not offered, sold or delivered and that it will not offer, sell or deliver, directly or indirectly, any of the Notes or distribute the pricing supplement and accompanying prospectus supplement and prospectus or any other material relating to the Notes, in or from any jurisdiction except under circumstances that will, to the best of its knowledge and belief, result in compliance with the applicable laws and regulations thereof.

Without prejudice to the other provisions of this Terms Agreement and the Distribution Agreement, and except for registration under the 1933 Act and compliance with the 1933 Act Regulations, the Company shall not have any responsibility for, and each Underwriter severally agrees with the Company that each such Underwriter and its respective affiliates will obtain, any consent, approval or authorization required by them for the subscription, offer, sale or delivery by them of any of the Notes under the laws and regulations in force in any foreign jurisdiction to which they are subject or in or from which they make such subscription, offer, sale or delivery of any of the Notes.

5

If the foregoing is in accordance with your understanding of our agreement, please sign and return to the Underwriters a counterpart hereof, whereupon this instrument along with all counterparts will become a binding agreement between the Company and the Underwriters in accordance with its terms.

6

Accepted:

7

SCHEDULE I

December 4, 2007

Banc of America Securities LLC

BMO Capital Markets Corp.

Deutsche Bank Securities Inc.

Merrill Lynch, Pierce, Fenner & Smith

Incorporated

Mitsubishi UFJ Securities International plc

Gentlemen:

I am Senior Vice President-Deputy General Counsel-Corporate of The Walt Disney Company, a Delaware corporation (“Disney”), and have acted as such in connection with the issuance and sale by Disney of Medium-Term Notes, Series C, entitled 4.70% Global Notes due 2012 (the “Notes”) pursuant to the Terms Agreement, dated November 29, 2007 (the “Terms Agreement”), between Disney and each of Banc of America Securities LLC, BMO Capital Markets Corp., Deutsche Bank Securities Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and Mitsubishi UFJ Securities International plc (collectively, the “Underwriters”).

This letter is being furnished to you pursuant to the Terms Agreement.

In connection with this letter, I have examined and am familiar with originals or copies, certified or otherwise identified to my satisfaction, of such documents as I have deemed necessary or appropriate as a basis for this letter, including (a) the Registration Statement on Form S-3 (Registration No. 333-122139), filed with the Securities and Exchange Commission (the “Commission”) on January 19, 2005, as amended by Amendment No. 1 thereto, filed with the Commission on February 4, 2005 (such Registration Statement (including the documents incorporated or deemed to be incorporated by reference in the Registration Statement or the Prospectus pursuant to Item 12 of Form S-3 under the 1933 Act (the “Incorporated Documents”)) and Amendment No. 1 thereto being hereinafter referred to collectively as the “Registration Statement”), pertaining to $5,000,000,000 aggregate offering price of Disney’s debt securities and other securities (the “Securities”), (b) the Prospectus, dated February 8, 2005, and the accompanying Prospectus Supplement, dated March 10, 2005 and Pricing Supplement, dated November 29, 2007, relating to the Notes, each of which were filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the 1933 Act (such Prospectus (including the Incorporated Documents), Prospectus Supplement and Pricing Supplement being hereinafter referred to collectively as the “Prospectus”), (c) executed copy of the Terms Agreement and (d) the Pricing Term Sheet attached as Schedule II to the Terms Agreement (“Term Sheet”).

I have made such inquiry of such officers of Disney and its subsidiaries and counsel for Disney and examined such corporate records, certificates of officers of Disney, officers of Disney’s subsidiaries and of public officials and such other documents and such questions of law and fact as I have considered necessary or appropriate for the purposes of this letter. In connection with my participation in the preparation of the Registration Statement, Prospectus and the Term Sheet, I have not verified, independently, nor do I pass upon or assume

any responsibility for, explicitly or implicitly, the accuracy, completeness or fairness of the statements contained therein.

Based upon and subject to the foregoing, nothing has come to my attention that leads me to believe that (a) the Registration Statement at the time such Registration Statement became effective contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (b) the Pricing Disclosure Package, at the Applicable Time, contained any untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, or (c) the Prospectus, as of the date of the Terms Agreement or as of the date hereof, contained or contains any untrue statement of a material fact or omitted or omits to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, except that, in each case, I express no opinion with respect to the financial statements, schedules and other financial data included or incorporated by reference therein or excluded therefrom or the exhibits to the Registration Statement, including the Trustee’s Statement of Eligibility and Qualification on Form T-1 under the Trust Indenture Act of 1939, as amended. As used in this paragraph, “Pricing Disclosure Package” means the base Prospectus dated as of February 8, 2005, and the accompanying Prospectus Supplement dated as of March 10, 2005 together with the Term Sheet.

This letter is rendered to you, in your capacity as Underwriters, in connection with the offering and sale of the Notes, and this letter may not be used, circulated, quoted or otherwise referred to or relied upon for any other purpose or by any other person without my prior express written permission.

Very truly yours,

2

SCHEDULE II

Filed Pursuant to Rule 433

Registration No. 333-122139
Pricing Term Sheet

The Walt Disney Company
4.70% Global Notes Due 2012

The Issuer has filed a Registration Statement (including a prospectus) with the Securities and Exchange Commission for the Offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Issuer has filed with the Securities and Exchange Commission for more complete information about the Issuer and this Offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the Offering will arrange to send you the prospectus if you request it by calling Banc of America Securities LLC toll-free at ###-###-####, or Deutsche Bank Securities Inc. toll-free at ###-###-####, or Merrill Lynch, Pierce, Fenner & Smith Incorporated, toll-free at ###-###-####.

2